Binbin Lu
Impact in
- Toxicology top 2%
- Bioactive Compounds and Antitumor Agents
-
- Natural Compounds in Disease Treatment
Papers in ⓘ
-
- RNA Interference and Gene Delivery 6
- Photosynthetic Processes and Mechanisms 5
- Advanced biosensing and bioanalysis techniques 3
- RNA modifications and cancer 2
-
- Lipid metabolism and biosynthesis 4
- Co-authors
- Mingyao Liu (5 shared papers)Zhengfang Yi (5 shared papers)Christoph Benning (5 shared papers)Weijing Qu (2 shared papers)Xiufeng Pang (2 shared papers)Koichiro Awai (4 shared papers)Changcheng Xu (4 shared papers)Yanmin Dong (3 shared papers)
- Journals
- International Journal of Pharmaceutics (3 papers)Journal of Biological Chemistry (2 papers)The FASEB Journal (2 papers)Molecular Cancer Therapeutics (1 paper)Cancer Research (1 paper)
- Partner nations
- ChinaUnited StatesJapan
In The Last Decade
Binbin Lu
23 papers receiving 836 citations
Peers
Comparison fields: 5 of 88
- Toxicology 75
- Complementary and alternative medicine 153
- Biochemistry 117
- Molecular Biology 547
- Biomaterials 59
Countries citing papers authored by Binbin Lu
This map shows the geographic impact of Binbin Lu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Binbin Lu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Binbin Lu more than expected).
Fields of papers citing papers by Binbin Lu
This network shows the impact of papers produced by Binbin Lu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Binbin Lu. The network helps show where Binbin Lu may publish in the future.
Co-authors
The 25 scholars most cited alongside Binbin Lu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 27 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2010 | 193 | |
| 2 | 2012 | 111 | |
| 3 | 2007 | 102 | |
| 4 | 2011 | 71 | |
| 5 | 2011 | 70 | |
| 6 | 2011 | 60 | |
| 7 | 2009 | 59 | |
| 8 | 2017 | 37 | |
| 9 | 2016 | 18 | |
| 10 | 2006 | 18 | |
| 11 | 2015 | 17 | |
| 12 | 2021 | 17 | |
| 13 | 2014 | 15 | |
| 14 | 2017 | 14 | |
| 15 | 2017 | 12 | |
| 16 | 2019 | 10 | |
| 17 | 2019 | 9 | |
| 18 | 2018 | 8 | |
| 19 | 2023 | 3 | |
| 20 | 2007 | 2 |
About Binbin Lu
Binbin Lu is a scholar working on Molecular Biology, Biochemistry, Plant Science, Oncology and Biomaterials, having authored 27 papers that have together received 849 indexed citations. Recurring topics across this work include RNA Interference and Gene Delivery (6 papers), Photosynthetic Processes and Mechanisms (5 papers), Lipid metabolism and biosynthesis (4 papers), Nanoparticle-Based Drug Delivery (3 papers), Advanced biosensing and bioanalysis techniques (3 papers), Invertebrate Immune Response Mechanisms (2 papers), Bioactive Compounds and Antitumor Agents (2 papers) and RNA modifications and cancer (2 papers). The work is most often cited by research in Toxicology (75 citations), Complementary and alternative medicine (153 citations), Biochemistry (117 citations), Molecular Biology (547 citations) and Biomaterials (59 citations). Binbin Lu has collaborated with scholars based in China, United States and Japan. Frequent co-authors include Mingyao Liu, Zhengfang Yi, Christoph Benning, Weijing Qu, Xiufeng Pang, Koichiro Awai, Changcheng Xu, Yanmin Dong, Jing Zhang and Bokyung Sung. Their work appears in journals such as International Journal of Pharmaceutics, Journal of Biological Chemistry, The FASEB Journal, Molecular Cancer Therapeutics and Cancer Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.